Clinical Observation Study of the Hydroxylapatite-coated SL-PLUS™ Hip Shaft

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-06-12

Study Completion Date

2020-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Summary from initial protocol

Goal: Validation of the HA (hydroxylapatite) coated SL-PLUS™ stem within an observation study

Study design: prospective, multicenter, observational, non-comparative study

Study population: 240 consecutive cases (HA-coated implants), 60 cases per study site

Intervention (if applicable): Implantation of a total hip endoprosthesis Main goals/endpoints: Radiological: radiolucent lines, osteolysis, hypo- and hypertrophy of the cortex, loosening of the implant or migration; clinical: Harris Hip Score, implant-related complications, revisions; patient questionnaires HOOS and EQ-5D

Type and extent of the risks associated with the study participation as well as benefits for the patient:

All patients will benefit from the hip prostheses without exception. There are no increased risks for the patients participating in the study compared to patients who do not participate. Normal, necessary follow-up exams will be performed over the course of 10 years. These follow-up exams will then be quantitatively evaluated within the scope of the study in accordance with a standardized protocol. Accordingly, the benefit for the patients from the participation in the study is currently not yet foreseeable.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem

NCT04122157

Primary Total Hip Arthroplasty

COMPLETED

Assessment of Implant Fixation and SF-36 for Short Hip-Stems - A Prospective Clinical Study

NCT04172129

Primary and Secondary Coxarthrosis Dysplasia Coxarthrosis Post-traumatic Necrosis of the Femoral Head

COMPLETED

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

NCT00757653

Femoral Neck Fractures

TERMINATED NA

Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures

NCT00756431

Osteoarthritis

WITHDRAWN NA

Treatment of Sub-capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

NCT00663468

Hip Fractures

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SL-PLUS™ hydroxylapatite coated cement free hip stem

Total Hip Arthroplasty using the SL-PLUS™ hydroxylapatite coated cement free hip stem

Total Hip Arthroplasty

Intervention Type DEVICE

Total Hip Arthroplasty using the SL-PLUS™ hydroxylapatite coated cement free hip stem

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Total Hip Arthroplasty

Total Hip Arthroplasty using the SL-PLUS™ hydroxylapatite coated cement free hip stem

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary total hip endoprosthesis of the side affected (unilateral or bilateral)
* Patient shall be provided with a HA-coated SL-PLUS™ stem
* Patient has no general medical contraindications regarding the surgery
* Signed informed consent form for the participation in the study
* X-ray examinations are possible
* Patient is willing to participate in the post-operative follow-up program
* Age: 18-75 years